Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-04-14 00:00:00 ET · period of report 2025-04-10 · accession 0001140361-25-013804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-14 | 2025-04-10 | RCKT | Shah Gaurav | CEO, Dir | P - Purchase | $5.08 | +20.0K | 792.7K | +3% | +$101.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-10 | P | A | 20,000 | $5.08 | 792,680 | D | — | — |